Sight Sciences to Present at the Upcoming Morgan Stanley 21st Annual Global Healthcare Conference
30 Agosto 2023 - 5:05PM
Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences,” or the
“Company”), an eyecare technology company focused on developing and
commercializing innovative technology intended to transform care
and improve patients’ lives, today announced plans to present at
the upcoming Morgan Stanley 21st Annual Global Healthcare
Conference in New York, NY.
Sight Sciences’ management is scheduled to
present on Tuesday, September 12, 2023, at 12:35 pm PT / 3:35 pm
ET. Interested parties may access a live and archived webcast of
the fireside chat on the “Investors” section of the company’s
website at: https://investors.sightsciences.com/.
About Sight SciencesSight
Sciences is an eyecare technology company focused on developing and
commercializing innovative solutions intended to transform care and
improve patients’ lives. Using minimally invasive or non-invasive
approaches to target the underlying causes of the world’s most
prevalent eye diseases, Sight Sciences seeks to create more
effective treatment paradigms that enhance patient care and
supplant conventional outdated approaches. The Company’s OMNI®
Surgical System is a minimally invasive glaucoma surgery (MIGS)
technology indicated to reduce intraocular pressure in adult
patients with primary open-angle glaucoma (POAG), the world’s
leading cause of irreversible blindness. The Company’s TearCare
System technology is 510(k) cleared for the application of
localized heat therapy in adult patients with evaporative dry eye
disease due to meibomian gland dysfunction (MGD) when used in
conjunction with manual expression of the meibomian glands,
enabling office-based clearance of gland obstructions by physicians
to address the leading cause of dry eye disease. The Company’s
SION™ Surgical Instrument is a manually operated device used in
ophthalmic surgical procedures to excise trabecular meshwork.
For more information, visit
www.sightsciences.com.
OMNI and TearCare are registered trademarks of
Sight Sciences.SION is a trademark of Sight Sciences.© 2023 Sight
Sciences. All rights reserved.
Investor contact:Philip
TaylorGilmartin
Group415.937.5406Investor.Relations@Sightsciences.com
Sight Sciences (NASDAQ:SGHT)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Sight Sciences (NASDAQ:SGHT)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024